GlaxoSmithKline UK

Stockley Park West, Uxbridge, Middlesex, UB11 1BT
Telephone: +44 (0)800 221 441
Fax: +44 (0)208 990 4328
Medical Information e-mail: customercontactuk@gsk.com

Patient Information Leaflet last updated on the eMC: 28/09/2010
PIL Imigran Tablets 50mg Imigran Tablets 100mg

When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.

Updated on 28/09/2010 and displayed until Current
Reasons for adding or updating:
  • Change to Further Information section
  • Change to date of revision
  • Correction of spelling/typing errors
  • Change to warnings or special precautions for use
Updated on 23/05/2008 and displayed until 28/09/2010
Reasons for adding or updating:
  • Change to date of revision
  • Addition of joint PIL covering all presentations
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change due to user-testing of patient information
Updated on 15/01/2007 and displayed until 23/05/2008
Reasons for adding or updating:
  • Change of manufacturer
  • Change to date of revision
  • Change to manufacturer contact details
  • PIL Retired combination of strengths
Updated on 07/06/2006 and displayed until 15/01/2007
Reasons for adding or updating:
  • Change to warnings or special precautions for use
  • Change to side-effects
  • Change to Further Information section
  • Change to date of revision
  • Change to how to administer the medicine
Updated on 19/01/2004 and displayed until 07/06/2006
Reasons for adding or updating:
  • Update to PIL
Updated on 24/10/2003 and displayed until 19/01/2004
Reasons for adding or updating:
  • Update to PIL
Updated on 24/09/2001 and displayed until 24/10/2003
Reasons for adding or updating:
  • Update to PIL
Updated on 29/01/2001 and displayed until 24/09/2001
Reasons for adding or updating:
  • No reasons supplied
Updated on 24/11/2000 and displayed until 29/01/2001
Reasons for adding or updating:
  • No reasons supplied

Active Ingredients/Generics

 
   sumatriptan succinate